SCHEMBL7525467

SCHEMBL7525467

CC(C)C1=CCCc2cnc(Nc3ccc(N4CCNCC4)cc3)nc21

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 14/20 0.54
▸ CDK2 P24941 7/20 0.54
▸ CCNA2 P20248 5/20 0.54
▸ CCND3 P30281 4/20 0.54
▸ CDK6 Q00534 1/20 0.54
▸ CCND1 P24385 11/20 0.52
▸ CDK1 P06493 5/20 0.52
▸ CCNB1 P14635 5/20 0.52
▸ CCNE1 P24864 2/20 0.52
▸ CCNA1 P78396 2/20 0.50
▸ CCND2 P30279 1/20 0.48
▸ CCNT1 O60563 3/20 0.48
▸ CDK7 P50613 3/20 0.48
▸ CDK9 P50750 3/20 0.48
▸ CCNH P51946 3/20 0.48
▸ FLT3 P36888 1/20 0.48
▸ STK17A Q9UEE5 1/20 0.46
▸ IGF1R P08069 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086788 0.81 CDK4 (0.57) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6087139 0.80 CDK4 (0.58) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6086902 0.73 CDK4 (0.61) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL1115237 0.72 FLT3 (0.53) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6086831 0.72 CDK4 (0.61) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6087196 0.71 CDK4 (0.49) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6086798 0.71 IGF1R (0.50) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6086207 0.70 CDK4 (0.56) CDK4CDK2CCNA2CCND3CDK6
SCHEMBL6088499 0.70 CDK4 (0.75) CDK4CDK2CCNA2CCND3CCND1
SCHEMBL6089773 0.70 CDK4 (0.53) CDK4CDK2CCNA2CCND3CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 — — EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 — — WO disclosed
Send feedback